Tag: Ludwig Hantson

AstraZeneca to acquire US biopharma company Alexion Pharmaceuticals for $39bn

pharmanewsdaily- December 14, 2020

AstraZeneca acquisition of Alexion Pharmaceuticals : Pharma giant AstraZeneca has signed a $39 billion deal to acquire Alexion Pharmaceuticals, a US biopharma company engaged in ... Read More

Alexion Pharmaceuticals to acquire Portola Pharmaceuticals for $1.4bn

pharmanewsdaily- May 6, 2020

Alexion acquisition of Portola : Alexion Pharmaceuticals has agreed to acquire Portola Pharmaceuticals, a commercial-stage biopharma company focused on life-threatening blood-related disorders, for $1.41 billion. ... Read More

Alexion to acquire Achillion to strengthen rare diseases portfolio

pharmanewsdaily- October 17, 2019

Alexion acquisition of Achillion : Alexion Pharmaceuticals has agreed to acquire rival US pharma company Achillion Pharmaceuticals for about $930 million in an all-cash deal ... Read More

Alexion to acquire Boston-based Syntimmune in $1.2bn deal

pharmanewsdaily- September 30, 2018

Alexion acquisition of Syntimmune : US pharma company Alexion Pharmaceuticals has signed a deal of around $1.2 billion to acquire Syntimmune, a Boston-based clinical-stage biotech ... Read More

Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m

pallavi123- April 14, 2018

Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused ... Read More